Longevity PapersAbout
← All papers
RESEARCH PAPER / 2025-05-05

Do circulating sphingolipid species correlate with age? A study in a normoglycemic biracial population.

Naser Aliye Feto, Peace Asuzu, Jim Wan, Frankie Stentz, Sam Dagogo-Jack, Nawajes Mandal

Departments of Ophthalmology, Anatomy and Neurobiology, University of Tennessee Health Science Center, 930 Madison Ave., Memphis, TN, 38163, USA.Departments of Ophthalmology, Anatomy and Neurobiology, University of Tennessee Health Science Center, 930 Madison Ave., Memphis, TN, 38163, USA. · pubmed

Abstract

Sphingolipids (SPLs) are essential membrane lipids with significant bioactive roles involved in various cellular processes, and their alterations have been found to be linked to many diseases, including age-related diseases. However, comprehensive studies on the association of plasma sphingolipids with aging in large, diverse cohorts remain limited. The objective of this study was to investigate the relationship between plasma sphingolipid levels and aging in a cohort of 240 normoglycemic, biracial individuals (Black and White), aged 19-65 years. Using a targeted lipidomics approach, we measured 76 sphingolipid species using liquid chromatography-tandem mass spectrometry (LC-MS/MS) in picomole/mL and determined changes in their levels with age and their correlations with aging. We found significant age-related changes in several sphingolipid species, including ceramide C18:1 and several very long-chain sphingomyelins (VLC SMs), such as C28:1 and C30:1, increases with age, showing a positive correlation. On the other hand, glycosphingolipids (monohexosylceramide, MHC; lactosylceramide, LacCer) and sphingosine (So) showed strong negative correlations with aging. A significant correlation was also observed between the ratios of saturate/monosaturated sphingolipid species with aging. In conclusion, our findings provide novel insights into the dynamic changes of circulating sphingolipids with aging. Specific sphingolipid species, such as Ceramide C18:1 and SM, accumulate with age, while others, including MHC, LacCer, and So decrease. These results suggest that the plasma SPL profile may provide valuable information about healthy aging and age-associated disease conditions.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The study identifies specific changes in circulating sphingolipid levels with aging, suggesting potential biomarkers for healthy aging and age-associated diseases. The research explores the biochemical changes associated with aging, which could contribute to understanding the underlying mechanisms of aging and longevity.

Author of this paper? Send a correction.